Salesforce (NYSE:CRM) Shares Down 3.1% - Time to Sell?

Key Points

• Shares fell about 3.1% to roughly $181 intraday with trading volume below average, a pullback attributed to profit-taking and the stock's weak year-to-date performance.
• Salesforce is pivoting heavily to AI agents—launching Agentforce Operations, deepening Google Cloud integration and scoring enterprise wins like Merck—which analysts view as a growth catalyst but note heightened competition (e.g., Microsoft) that raises execution risk.
• The company posted an earnings beat with revenue and EPS up year-over-year, raised its dividend to $0.44, and authorized a $25 billion buyback, while the analyst consensus remains a "Moderate Buy" despite some lowered price targets.

Salesforce Inc. (NYSE:CRM - Get Free Report)'s stock price fell 3.1% during trading on Wednesday . The company traded as low as $179.58 and last traded at $181.1660. 10,256,319 shares traded hands during mid-day trading, a decline of 21% from the average session volume of 12,913,151 shares. The stock had previously closed at $186.99.

Trending Headlines about Salesforce

Here are the key news stories impacting Salesforce this week:

• Positive Sentiment: Company reoriented around AI agents and launched Agentforce Operations to automate cross-system back-office work — a strategic shift that underpins Salesforce’s long-term growth story and supports upgraded revenue targets. Salesforce (CRM) Launches Agentforce Operations to Automate Complex Cross-System Back-Office Tasks
• Positive Sentiment: Deeper Google Cloud integration and new AI-focused revenue segments are being highlighted as catalysts that could expand addressable market and support valuation upside as agents get traction. Salesforce (CRM) Valuation Check As AI Agent Push And Google Cloud Integration Gain Traction
• Positive Sentiment: Commercial traction: Merck Animal Health selected Salesforce’s Agentforce Life Sciences for customer engagement, signaling enterprise demand for the new agent-driven offerings. Merck Animal Health Selects Salesforce’s Agentforce Life Sciences for Customer Engagement to Transform Animal Care and Enhance Support Experiences for Employees
• Positive Sentiment: Institutional/analyst support: Barclays named CRM a top pick in infrastructure software and high-profile investors have touted the name; sell-side consensus remains “Buy,” which can provide a floor for sentiment. Is the Market Missing the Point on Salesforce Inc (CRM)’s AI Positioning?
• Neutral Sentiment: Analyst ratings are positive on average, but some commentary warns that consensus recommendations can be overly optimistic — useful context but not an immediate catalyst. Wall Street Analysts See Salesforce (CRM) as a Buy: Should You Invest?
• Neutral Sentiment: Valuation and peer comparisons (e.g., CRM vs. SPOT) are being debated — useful for longer-term allocation decisions but mixed in terms of near-term price impact. CRM vs. SPOT: Which Stock Is the Better Value Option?
• Negative Sentiment: Shares are down despite broader market gains; investors are likely taking profits and reacting to the stock’s weak year-to-date performance and lingering valuation concerns. Salesforce (CRM) Stock Drops Despite Market Gains: Important Facts to Note
• Negative Sentiment: Competition with Microsoft and other large cloud/AI players is intensifying around AI agents — the rivalry increases execution risk and could pressure multiples if market leaders consolidate share. Salesforce and Microsoft escalate AI agent rivalry in CRM

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on CRM shares. Barclays lowered their target price on shares of Salesforce from $265.00 to $252.00 and set an "overweight" rating on the stock in a report on Thursday, February 26th. Wells Fargo & Company lowered their target price on shares of Salesforce from $235.00 to $210.00 and set an "equal weight" rating on the stock in a report on Thursday, February 26th. The Goldman Sachs Group reissued a "buy" rating and set a $281.00 target price on shares of Salesforce in a report on Thursday, February 26th. Wall Street Zen cut shares of Salesforce from a "buy" rating to a "hold" rating in a report on Saturday, April 18th. Finally, UBS Group lowered their target price on shares of Salesforce from $260.00 to $200.00 and set a "neutral" rating on the stock in a report on Tuesday, February 17th. One investment analyst has rated the stock with a Strong Buy rating, twenty-six have issued a Buy rating, eleven have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $279.18.

Salesforce Price Performance

The firm has a market cap of $148.23 billion, a P/E ratio of 23.20, a PEG ratio of 1.29 and a beta of 1.14. The business's fifty day simple moving average is $186.70 and its 200-day simple moving average is $219.76. The company has a current ratio of 0.76, a quick ratio of 0.76 and a debt-to-equity ratio of 0.18.

Salesforce (NYSE:CRM - Get Free Report) last released its quarterly earnings results on Wednesday, February 25th. The CRM provider reported $3.81 earnings per share for the quarter, topping the consensus estimate of $3.05 by $0.76. The firm had revenue of $11.20 billion for the quarter, compared to analysts' expectations of $11.18 billion. Salesforce had a net margin of 17.96% and a return on equity of 15.38%. The business's quarterly revenue was up 12.1% on a year-over-year basis. During the same quarter in the prior year, the firm posted $2.78 earnings per share. Salesforce has set its FY 2027 guidance at 13.110-13.190 EPS and its Q1 2027 guidance at 3.110-3.130 EPS. As a group, analysts forecast that Salesforce Inc. will post 9.71 EPS for the current fiscal year.

Salesforce Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Thursday, April 23rd. Shareholders of record on Thursday, April 9th were given a dividend of $0.44 per share. The ex-dividend date was Thursday, April 9th. This is a positive change from Salesforce's previous quarterly dividend of $0.42. This represents a $1.76 annualized dividend and a yield of 1.0%. Salesforce's dividend payout ratio (DPR) is currently 22.54%.

Salesforce announced that its board has initiated a stock repurchase plan on Monday, March 16th that allows the company to buyback $25.00 billion in shares. This buyback authorization allows the CRM provider to repurchase up to 14.1% of its stock through open market purchases. Stock buyback plans are typically an indication that the company's leadership believes its stock is undervalued.

Insider Activity

In other Salesforce news, Director Laura Alber purchased 2,571 shares of the business's stock in a transaction on Thursday, March 19th. The stock was acquired at an average cost of $194.58 per share, for a total transaction of $500,265.18. Following the completion of the transaction, the director directly owned 9,530 shares in the company, valued at approximately $1,854,347.40. This represents a 36.94% increase in their position. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Director David Blair Kirk purchased 2,570 shares of the business's stock in a transaction on Wednesday, March 18th. The shares were acquired at an average price of $194.62 per share, with a total value of $500,173.40. Following the completion of the transaction, the director owned 13,689 shares of the company's stock, valued at approximately $2,664,153.18. This trade represents a 23.11% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Corporate insiders own 3.00% of the company's stock.

Institutional Trading of Salesforce

A number of institutional investors have recently modified their holdings of CRM. Rockland Trust Co. increased its stake in shares of Salesforce by 1,145.6% during the third quarter. Rockland Trust Co. now owns 13,066 shares of the CRM provider's stock valued at $3,097,000 after purchasing an additional 12,017 shares in the last quarter. Alps Advisors Inc. increased its stake in shares of Salesforce by 98.3% during the third quarter. Alps Advisors Inc. now owns 21,455 shares of the CRM provider's stock valued at $5,085,000 after purchasing an additional 10,633 shares in the last quarter. Midwest Trust Co increased its stake in shares of Salesforce by 2.3% during the third quarter. Midwest Trust Co now owns 187,071 shares of the CRM provider's stock valued at $44,336,000 after purchasing an additional 4,233 shares in the last quarter. Jones Financial Companies Lllp increased its stake in shares of Salesforce by 15.1% during the third quarter. Jones Financial Companies Lllp now owns 467,551 shares of the CRM provider's stock valued at $113,420,000 after purchasing an additional 61,270 shares in the last quarter. Finally, AGF Management Ltd. increased its stake in shares of Salesforce by 42.2% during the third quarter. AGF Management Ltd. now owns 281,054 shares of the CRM provider's stock valued at $66,610,000 after purchasing an additional 83,403 shares in the last quarter. 80.43% of the stock is currently owned by hedge funds and other institutional investors.

Salesforce Company Profile

Salesforce, founded in 1999 and headquartered in San Francisco, is a global provider of cloud-based software focused on customer relationship management (CRM) and enterprise applications. The company popularized the software-as-a-service (SaaS) model for CRM and has built a broad portfolio of products designed to help organizations manage sales, service, marketing, commerce and analytics through a unified, cloud-first platform.

Core offerings include Sales Cloud for sales automation, Service Cloud for customer support, Marketing Cloud for digital marketing and engagement, and Commerce Cloud for e-commerce.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.